The post-election landscape raises uncertainty for cannabis MSOs, with investors hoping for potential relief from the new administration. Verano (OTC:VRNOF), Green Thumb (OTC:GTBIF), and Gold Flora (OTCQB:GRAM) show mixed results, balancing strategic gains with regulatory challenges. While full federal legalization remains a distant possibility, Pablo Zuanic, from Zuanic & Associates, suggests a gradual shift towards rescheduling cannabis to Schedule III, potentially extending into late 2025.

Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. You can't afford to miss...